Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce L Levine

Showing results (11-20 of 185) with videos related to

Pageof 19
Sort By:
Cytotherapy|February 5, 2020
The long road to the first FDA-approved gene therapy: chimeric antigen receptor T cells targeting CD19Peter Braendstrup, Bruce L Levine, Marco Ruella
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2017
Showcasing Clinical Development and Production of Cellular TherapiesBruce L Levine, Andrew D Fesnak, Isabelle Riviere
Nature Reviews. Cancer|August 24, 2016
Engineered T cells: the promise and challenges of cancer immunotherapyAndrew D Fesnak, Carl H June, Bruce L Levine
Lancet (London, England)|March 1, 2025
Assessing the oncogenic risk: the long-term safety of autologous chimeric antigen receptor T cellsDaniel J Baker, Bruce L Levine, Carl H June
Molecular Therapy. Methods & Clinical Development|March 28, 2017
Global Manufacturing of CAR T Cell TherapyBruce L Levine, James Miskin, Keith Wonnacott, et al.
Scientific American|February 17, 2017
Cancer KillersAvery D Posey, Carl H June, Bruce L Levine
Discovery Medicine|May 28, 2016
Novel gene and cellular therapy approaches for treating HIVVijay G Bhoj, Suzanne R Thibodeaux, Bruce L Levine
Current Hematologic Malignancy Reports|August 2, 2017
Considerations in T Cell Therapy Product Development for B Cell Leukemia and Lymphoma ImmunotherapyAndrew D Fesnak, Patrick J Hanley, Bruce L Levine
Blood Advances|October 5, 2021
Adoptive T-cell therapy for Hodgkin lymphomaCarrie Ho, Marco Ruella, Bruce L Levine, et al.
Journal of Visualized Experiments : Jove|March 29, 2021
Production of Human CRISPR-Engineered CAR-T CellsSangya Agarwal, Nils Wellhausen, Bruce L Levine, et al.
Pageof 19

Showing results (11-20 of 185) with videos related to

Sort By:
Pageof 19
Cytotherapy|February 5, 2020
The long road to the first FDA-approved gene therapy: chimeric antigen receptor T cells targeting CD19Peter Braendstrup, Bruce L Levine, Marco Ruella
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2017
Showcasing Clinical Development and Production of Cellular TherapiesBruce L Levine, Andrew D Fesnak, Isabelle Riviere
Nature Reviews. Cancer|August 24, 2016
Engineered T cells: the promise and challenges of cancer immunotherapyAndrew D Fesnak, Carl H June, Bruce L Levine
Lancet (London, England)|March 1, 2025
Assessing the oncogenic risk: the long-term safety of autologous chimeric antigen receptor T cellsDaniel J Baker, Bruce L Levine, Carl H June
Molecular Therapy. Methods & Clinical Development|March 28, 2017
Global Manufacturing of CAR T Cell TherapyBruce L Levine, James Miskin, Keith Wonnacott, et al.
Scientific American|February 17, 2017
Cancer KillersAvery D Posey, Carl H June, Bruce L Levine
Discovery Medicine|May 28, 2016
Novel gene and cellular therapy approaches for treating HIVVijay G Bhoj, Suzanne R Thibodeaux, Bruce L Levine
Current Hematologic Malignancy Reports|August 2, 2017
Considerations in T Cell Therapy Product Development for B Cell Leukemia and Lymphoma ImmunotherapyAndrew D Fesnak, Patrick J Hanley, Bruce L Levine
Blood Advances|October 5, 2021
Adoptive T-cell therapy for Hodgkin lymphomaCarrie Ho, Marco Ruella, Bruce L Levine, et al.
Journal of Visualized Experiments : Jove|March 29, 2021
Production of Human CRISPR-Engineered CAR-T CellsSangya Agarwal, Nils Wellhausen, Bruce L Levine, et al.
Pageof 19